首页 | 本学科首页   官方微博 | 高级检索  
     


Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Authors:Beatrice Seddon  Sandra J Strauss  Jeremy Whelan  Michael Leahy  Penella J Woll  Fiona Cowie  Christian Rothermundt  Zoe Wood  Charlotte Benson  Nasim Ali  Maria Marples  Gareth J Veal  David Jamieson  Katja Küver  Roberto Tirabosco  Sharon Forsyth  Stephen Nash  Hakim-Moulay Dehbi  Sandy Beare
Affiliation:1. University College London Hospitals NHS Foundation Trust, London, UK;2. UCL Cancer Institute, London, UK;3. The Christie NHS Foundation Trust, Manchester, UK;4. University of Sheffield, Sheffield, UK;5. Beatson West of Scotland Cancer Centre, Glasgow, UK;6. Kantonsspital, St Gallen, Switzerland;7. Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland;8. The Royal Marsden NHS Foundation Trust, London, UK;9. The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK;10. The Leeds Teaching Hospitals NHS Trust, Leeds, UK;11. Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK;12. Royal National Orthopaedic Hospital, Stanmore, UK;13. Cancer Research UK and UCL Cancer Trials Centre, London, UK
Abstract:
Keywords:Correspondence to: Dr Beatrice Seddon   London Sarcoma Service   Department of Oncology   University College London Hospitals NHS Foundation Trust   London   NW1 2PG   UK
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号